• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human N-myc proto-oncogene protein (MYCN)

This Recombinant Human MYCN protein is an essential resource for cancer researchers. N-myc proto-oncogene protein, also known as Class E basic helix-loop-helix protein 37 (bHLHe37), plays a critical role in cancer research. This full-length protein (1-464aa) is expressed in yeast and serves as a powerful tool in various oncology applications. Equipped with an N-terminal 6xHis-tag, our Recombinant Human MYCN protein facilitates effortless purification and detection. With a purity greater than 90% as determined by SDS-PAGE, you can rely on the exceptional quality of this protein to advance your cancer research projects. Choose between liquid and lyophilized powder forms to best suit your experimental requirements and elevate your research with our Recombinant Human MYCN protein.

ACP02558

This Recombinant Human MYCN protein is an essential resource for cancer researchers. N-myc proto-oncogene protein, also known as Class E basic helix-loop-helix protein 37 (bHLHe37), plays a critical role in cancer research. This full-length protein (1-464aa) is expressed in yeast and serves as a powerful tool in various oncology applications.
Equipped with an N-terminal 6xHis-tag, our Recombinant Human MYCN protein facilitates effortless purification and detection. With a purity greater than 90% as determined by SDS-PAGE, you can rely on the exceptional quality of this protein to advance your cancer research projects. Choose between liquid and lyophilized powder forms to best suit your experimental requirements and elevate your research with our Recombinant Human MYCN protein.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02558 Target Namemycn
FormLiquid or Lyophilized powderExpression SystemYeast
Expression Range1-464aaMol Weight51.6kDa
Protein LengthFull lengthPurityGreater than 90% as determined by SDS-PAGE.Greater than 90% as determined by SEC-HPLC.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP04198
Background Information
  • Uniprot Id

    P04198

  • Target Species

    Human

  • Target Name

    MYCN

  • Target Full Name

    N-myc proto-oncogene protein

  • Target Function

    Positively regulates the transcription of MYCNOS in neuroblastoma cells.

  • Target Involvement

    Feingold syndrome 1 (FGLDS1)

  • Target Subcellular Location

    Nucleus.

  • Target Tissue Specificity

    Expressed in the neuronal cells of the cerebrum, neuroblastomas and thyroid tumors (at protein level).

  • Target Research Area

    Cancer

  • Target Synonyms

    bHLHe37; Class E basic helix-loop-helix protein 37; MODED; mycn; MYCN_HUMAN; N myc; N myc proto oncogene protein; N-myc proto-oncogene protein; Neuroblastoma derived v myc avian myelocytomatosis viral related oncogene; Neuroblastoma MYC oncogene; NMYC; NMYC proto oncogene protein; ODED; Oncogene NMYC; pp65/67; V myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog; v myc avian myelocytomatosis viral related oncogene neuroblastoma derived; v myc myelocytomatosis viral related oncogene neuroblastoma derived

  • Target Background

    This gene is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. This protein is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human N-myc proto-oncogene protein (MYCN) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification